πŸ‡ΊπŸ‡Έ FDA
Patent

US 11306123

Heterotandem bicyclic peptide complex

granted A61KA61K38/00A61K38/12

Quick answer

US patent 11306123 (Heterotandem bicyclic peptide complex) held by BicycleTx Limited expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BicycleTx Limited
Grant date
Tue Apr 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/00, A61K38/12, A61K47/641, A61K9/0019